10% Owner Mark Strome Increases Stake in Zivo Bioscience with $195K Stock Purchase

summarizeSummary

Mark E. Strome, a 10% owner of Zivo Bioscience, acquired an additional $195,400 worth of common stock, further increasing his stake in the company.

check_boxKey Events

• Significant Insider Purchase

  Mark E. Strome, a 10% owner, purchased 22,000 shares of common stock for $195,400 on February 12, 2026, at an average price of $9.77 per share.

• Continued Insider Accumulation

  This purchase adds to a pattern of recent insider buying, following approximately $200,000 in purchases by the CEO and a Director on January 28, 2026.

• Increased Stake

  Following this transaction, the reporting persons now indirectly hold 472,942 shares of Zivo Bioscience.

auto_awesomeAnalysis

This significant open market purchase by a 10% owner signals continued confidence in Zivo Bioscience. The transaction, valued at $195,400, represents a notable investment relative to the company's market capitalization. This follows recent insider accumulation by the CEO and a Director in late January, reinforcing a positive trend of insider buying. Such sustained insider interest can be a bullish indicator for investors, suggesting that key stakeholders believe the stock is undervalued or that positive developments are anticipated.